NasdaqGS - Nasdaq Real Time Price USD

Legend Biotech Corporation (LEGN)

Compare
34.81 -0.31 (-0.88%)
As of 10:10:14 AM EST. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
520,183.00
285,143.00
117,005.00
68,826.00
75,000.00
Cost of Revenue
193,109.00
144,214.00
65,363.00
--
--
Gross Profit
327,074.00
140,929.00
51,642.00
68,826.00
75,000.00
Operating Expense
675,772.00
580,414.00
507,262.00
461,113.00
301,793.00
Operating Income
-348,698.00
-439,485.00
-455,620.00
-392,287.00
-226,793.00
Net Non Operating Interest Income Expense
42,569.00
32,693.00
-2,614.00
71.00
-1,279.00
Other Income Expense
-39,327.00
-113,326.00
12,510.00
-14,980.00
-80,213.00
Pretax Income
-345,456.00
-520,118.00
-445,724.00
-407,196.00
-308,285.00
Tax Provision
2,672.00
-1,864.00
625.00
-3,614.00
-41,912.00
Net Income Common Stockholders
-348,128.00
-518,254.00
-446,349.00
-403,582.00
-266,373.00
Diluted NI Available to Com Stockholders
-348,128.00
-518,254.00
-446,349.00
-403,582.00
-266,373.00
Basic EPS
-1.92
-2.94
-2.80
-2.74
-2.56
Diluted EPS
-1.92
-2.94
-2.80
-2.74
-2.56
Basic Average Shares
182,448.34
176,082.71
159,041.96
140,851.65
118,152.62
Diluted Average Shares
182,448.34
176,082.71
159,041.96
140,851.65
118,152.62
Total Expenses
868,881.00
724,628.00
572,625.00
461,113.00
301,793.00
Net Income from Continuing & Discontinued Operation
-348,128.00
-518,254.00
-446,349.00
-403,582.00
-266,373.00
Normalized Income
-340,018.65
-433,507.35
-467,830.50
-397,437.80
-266,470.63
Interest Income
64,852.00
54,487.00
8,182.00
971.00
2,930.00
Interest Expense
22,283.00
21,794.00
10,796.00
900.00
195.00
Net Interest Income
42,569.00
32,693.00
-2,614.00
71.00
-1,279.00
EBIT
-323,173.00
-498,324.00
-434,928.00
-406,296.00
-308,090.00
EBITDA
-301,259.00
-477,873.00
-416,536.00
-392,379.00
-298,157.00
Reconciled Cost of Revenue
193,109.00
144,214.00
65,363.00
--
--
Reconciled Depreciation
21,914.00
20,451.00
18,392.00
13,917.00
9,933.00
Net Income from Continuing Operation Net Minority Interest
-348,128.00
-518,254.00
-446,349.00
-403,582.00
-266,373.00
Total Unusual Items Excluding Goodwill
-10,265.00
-85,087.00
21,503.00
-6,200.00
113.00
Total Unusual Items
-10,265.00
-85,087.00
21,503.00
-6,200.00
113.00
Normalized EBITDA
-290,994.00
-392,786.00
-438,039.00
-386,179.00
-298,270.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-2,155.65
-340.35
21.50
-55.80
15.37
12/31/2020 - 6/5/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ACLX Arcellx, Inc.
84.25
+0.54%
 
BGNE BeiGene, Ltd.
178.62
-0.41%
 
ANAB AnaptysBio, Inc.
16.24
+4.17%
 
NUVL Nuvalent, Inc.
86.43
-0.50%
 
COGT Cogent Biosciences, Inc.
8.18
+0.37%
 
CGON CG Oncology, Inc.
29.15
+1.34%
 
BCYC Bicycle Therapeutics plc
14.15
+2.43%
 
KURA Kura Oncology, Inc.
9.69
+0.57%
 
RLAY Relay Therapeutics, Inc.
4.7750
+1.38%
 
SLRN Acelyrin, Inc.
3.2085
-0.67%